Quetiapine Fumarate
- Product NDC
- 70518-2702
- 11-digit product format
- 705182702
- Labeler code
- 70518
- Product ID
- 70518-2702_ccff1f3b-ceb1-6d86-e053-2995a90a7ac3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Quetiapine Fumarate
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA206260
- Marketing category
- ANDA
- Marketing start
- 2020-04-20
- Marketing end
- 0000-00-00
- Substance
- QUETIAPINE FUMARATE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2702-0 | 70518270200 | 30 POUCH in 1 BOX (70518-2702-0) > 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-2702-1) | 30 pouch | 2020-04-20 | 0000-00-00 | No | No | Current |